Changyu He
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 5
- Cancer-related gene regulation 3
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 10
- Co-authors
- Bingya Liu (19 shared papers)Luyang Zhang (1 shared paper)Pei Xue (1 shared paper)Jing Ping Sun (1 shared paper)Xiao Yang (1 shared paper)Bo Feng (1 shared paper)Zirui He (1 shared paper)Minhua Zheng (1 shared paper)
- Journals
- Oncotarget (4 papers)Frontiers in Oncology (4 papers)Future Oncology (3 papers)Polymer Chemistry (3 papers)Polymer Bulletin (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Changyu He
40 papers receiving 1.2k citations
Changyu He's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 482
- Biomaterials 213
- Molecular Biology 719
- Oncology 103
- Pulmonary and Respiratory Medicine 104
Countries citing papers authored by Changyu He
This map shows the geographic impact of Changyu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyu He more than expected).
Fields of papers citing papers by Changyu He
This network shows the impact of papers produced by Changyu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyu He. The network helps show where Changyu He may publish in the future.
Co-authors
The 25 scholars most cited alongside Changyu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST Hit paper breakdown → | 2020 | 412 |
| 2 | 2017 | 122 | |
| 3 | 2015 | 74 | |
| 4 | 2017 | 71 | |
| 5 | 2014 | 60 | |
| 6 | 2019 | 58 | |
| 7 | 2016 | 32 | |
| 8 | 2014 | 29 | |
| 9 | 2017 | 29 | |
| 10 | 2021 | 25 | |
| 11 | 2020 | 25 | |
| 12 | 2015 | 21 | |
| 13 | 2018 | 20 | |
| 14 | 2016 | 19 | |
| 15 | 2016 | 19 | |
| 16 | 2017 | 16 | |
| 17 | 2016 | 16 | |
| 18 | 2021 | 14 | |
| 19 | 2022 | 13 | |
| 20 | 2020 | 12 |
About Changyu He
Changyu He is a scholar working on Molecular Biology, Biomaterials, Pulmonary and Respiratory Medicine, Organic Chemistry and Oncology, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Gastric Cancer Management and Outcomes (9 papers), Advanced Polymer Synthesis and Characterization (6 papers), RNA Interference and Gene Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (482 citations), Biomaterials (213 citations), Molecular Biology (719 citations), Oncology (103 citations) and Pulmonary and Respiratory Medicine (104 citations). Changyu He has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Bingya Liu, Luyang Zhang, Pei Xue, Jing Ping Sun, Xiao Yang, Bo Feng, Zirui He, Minhua Zheng, Sen Zhang and Lu Zang. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Future Oncology, Polymer Chemistry and Polymer Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.